EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2021 • Amarillo Biosciences Inc • Pharmaceutical preparations • Texas
This Agreement (the "Agreement") is effective as of the 1st day of January 2021 (“Effective Date”) by and between, DR. STEPHEN T. CHEN, Ph.D. (the "EMPLOYEE"), and AMARILLO BIOSCIENCES, INC., a Texas Corporation ("EMPLOYER").
SETTLEMENT AGREEMENT AND MUTUAL GENERAL RELEASESettlement Agreement • March 30th, 2021 • Amarillo Biosciences Inc • Pharmaceutical preparations • Texas
This Settlement Agreement and Mutual General Release (the “Agreement”), effective as of December 24, 2020 (“Effective Date”), is made and entered into by and between AMARILLO BIOSCIENCES, INC. (“ABI”), on the one hand, and BERNARD COHEN (“COHEN”), on the other hand, each of which shall be referred to as a “Party” hereto and collectively as the “Parties hereto” or “the Parties to this Agreement.”
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2021 • Amarillo Biosciences Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 1 is made by and between AMARILLO BIOSCIENCES, INC., a Texas corporation, inclusive of any Affiliates or subsidiaries (“ABI”) and STEPHEN T. CHEN, Ph.D. (“EMPLOYEE”) to that certain Employment Agreement between the parties made effective January 1, 2021 (“Agreement”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2021 • Amarillo Biosciences Inc • Pharmaceutical preparations • Texas
This Agreement (the "Agreement") is effective as of the 1st day of January 2021 (“Effective Date”) by and between, BERNARD COHEN (the "EMPLOYEE"), and AMARILLO BIOSCIENCES, INC., a Texas Corporation ("EMPLOYER").
AMENDMENT TO CONSULTING AGREEMENTConsulting Agreement • March 30th, 2021 • Amarillo Biosciences Inc • Pharmaceutical preparations
THIS AMENDMENT (“Amendment’) is made on this 25th day of November 2020 to that certain Consulting Agreement dated May 3, 2018 (“CA”) by and between Amarillo Biosciences, Inc., a company organized under the laws of the State of Texas and/or its affiliates (“ABI”) and i2China Management Group, LLC, a Delaware limited liability company (“Consultant”) as follows.
